Usana Health Sciences Inc (USNA) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jul 04 2026 to Jun 28 2025 - CSIMarket
CSIMarket
 


Usana Health Sciences Inc   (NYSE: USNA)


Usana Health Sciences Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Usana Health Sciences Inc 's ROA in the second quarter of 2026?
Usana Health Sciences Inc recorded a cumulative net loss of $-29 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -4.02%.

However, within the Consumer Non Cyclical sector 100 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jul 04 2026 quarter, so far to 2085, from total ROA ranking in the first quarter of 2026 at 2288.

What is ROA?



Return On Assets (Jul 04 2026)
II. Quarter
(Apr 04 2026)
I. Quarter
(Jan 03 2026)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Total Assets Change -4.26 % 1.37 % -0.33 % 10.82 % 19.39 %
Y / Y Net Income Change - -25.09 % - - 0.12 %
Net Income (TTM) in million -29 9 11 18 35
Return On Assets (TTM) -4.02 % 1.24 % 1.57 % 2.4 % 4.87 %
USNA's Total Ranking # 2085 # 2288 # 1742 # 1218 # 1205
Total Assets (TTM) in million 703 739 739 727 735
Seq. Total Assets Change -4.84 % 0.05 % 1.66 % -1.08 % 0.76 %
Seq. Net Income Change - - - - 12.42 %



Return On Assets Company Ranking
Within: No.
Industry # 9
Sector # 101
Overall # 2895

Return On Assets Statistics
High Average Low
28.1 %
17.3 %
-4.02 %
(Jun 29 2013)   (Jul 04 2026)





Financial Statements
Usana Health Sciences Inc 's Assets $ 703 million USNA's Balance sheet
Usana Health Sciences Inc 's Income $ -28 million Quarterly USNA's Income Statement
USNA's Income by Division See USNA's Income by Division



Annual Return On Assets (Jan 03 2026)
FY 2025
(Dec 28 2024)
FY 2023
(Dec 31 2022)
FY 2022
(Jan 02 2021)
FY 2020
(Dec 28 2019)
FY 2019
Y / Y Total Assets Change 0.84 % 27.25 % -8.52 % 24.34 % -7.85 %
Total Assets in million 743 737 579 633 509
Y / Y Net Income Change -72.71 % -39.35 % -44.37 % 24.01 % -20.36 %
Net Income in million 11 42 69 125 101
Annual Return On Assets 1.54 % 5.71 % 11.98 % 19.7 % 19.75 %




Comment on USNA's ROA in the fiscal year ending 2025
In the fiscal year 2025 Usana Health Sciences Inc 's ROA decreased compared to previous year to 1.54 %, due to deterioration of net income -72.71 % to $11.48 million, from $42.06 million a year ago, as USNA's assets were $742.92 million.


More Return On Assets Ratios
USNA's' Return on Assets at Yahoo Finance
Legal Cannabis Industry Return On Assets Trends and Statistics
Consumer Non Cyclical Sector Roa Statistics
Roa Trends for overall market
USNA's Roa Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for USNA's Competitors
Subscribers only: Roa for Usana Health Sciences Inc 's Suppliers
Subscribers only: Return On Assets for USNA's Customers

You may also want to know
USNA's Roi USNA's Inventory Turnover Ratio USNA's Growth Rates USNA's Dividend Comparisons
USNA's Profitability Ratios USNA's Asset Turnover Ratio USNA's Dividend Growth
USNA's Roe USNA's Valuation Ratios USNA's Financial Strength Ratios USNA's Dividend Payout Ratio



Companies with similar Return On Assets at Jul 04 2026, within Consumer Non Cyclical Sector ROA


Date modified: 2026-09-26T07:14:02+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.